Medtech Guidance Tracker - January 2016
This article was originally published in SRA
Executive Summary
Click on the links to access the documents.
Country
Organization
Document
Status
International
AHWP
Regulation of Combination Products – a Review of International Practice
Final
International
AHWP
Final
International
AHWP
Definition of the Terms "Medical Device" and "In Vitro Diagnostic (IVD) Medical Device"
Final
International
AHWP
Guidance Document on Qualification of Medical device Software
Final
International
AHWP
Final
International
AHWP
Final
International
AHWP
Clinical Evidence for Medical Device – Key Definitions and Concepts
Final
International
AHWP
Clinical Evidence for IVD Medical Device – Key Definitions and Concept
Final
International
AHWP
Final
International
AHWP
Final
International
AHWP
Final
International
AHWP
Final
International
AHWP
Final
EU
EUnetHTA
Final
Germany
BfArM
Final
Malaysia
MDA
Final
US
FDA
Draft
US
FDA
Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices
Draft
US
FDA
Draft
US
FDA
Draft
US
FDA
Final
US
FDA
Applying Human Factors and Usability Engineering to Medical Devices
Final
You may also be interested in...
Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab
Outlook Therapeutics’ intravitreally injected Lytenava has won the thumbs up from the European Medicines Agency. The company is assessing both direct commercialization of the product and partnering in Europe on a country-by-country basis.
EU CHMP Opinions And MAA Updates
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.
EMA Says Yes To 12 New Drugs Including Pfizer/AbbVie’s Antibiotic Combo
Emblaveo, for fighting infections caused by multidrug-resistant bacteria, is among the latest batch of medicines that the European Medicines Agency says should be approved for use in the EU.